Login / Signup

Cortical [18 F]PI-2620 Binding Differentiates Corticobasal Syndrome Subtypes.

Carla PalleisMatthias BrendelAnika FinzeEndy WeidingerKai BötzelAdrian DanekLeonie BeyerAlexander NitschmannMaike KernGloria BiecheleBoris-Stephan RauchmannJan HäckertMatthias HöllerhageAndrew W StephensAlexander DrzezgaThilo van EimerenVictor L VillemagneAndreas SchildanHenryk BarthelMarianne PattOsama Sabrinull nullPeter BartensteinRobert PerneczkyChristian HaassJohannes LevinGünter U Höglinger
Published in: Movement disorders : official journal of the Movement Disorder Society (2021)
Our data indicate a value of [18 F]PI-2620 for evaluating corticobasal syndrome, providing quantitatively and regionally distinct signals in β-amyloid-positive as well as β-amyloid-negative corticobasal syndrome. In corticobasal syndrome, [18 F]PI-2620 may potentially serve for a differential diagnosis and for monitoring disease progression. © 2021 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Keyphrases
  • case report
  • randomized controlled trial
  • systematic review
  • electronic health record
  • artificial intelligence
  • binding protein
  • dna binding
  • data analysis